Thang Xuan Do, Ha Thi Nguyen, Phuong Thi Lan Nguyen, Mai Thi Tuyet Kieu, Tuan Viet Duong, Van Nu Hanh Pham. "Cost-utility analysis of lenvatinib and sorafenib for the first-line treatment of unresectable hepatocellular carcinoma in Vietnam: Evidence from a lower-middle income country." PLoS ONE, 2026. doi:10.1371/journal.pone.0345212